Popular Articles

Feb 01, 2015
Pharmaceutical Executive
As more new products vie for payer and prescriber attention, the stakes around launch success are higher than ever. Here are key traps to avoid in getting things right—when it really counts.
Jan 12, 2015
Pharmaceutical Executive
Pharm Exec’s annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead.
Sep 08, 2014
Pharmaceutical Executive
In 1955, the broadcaster CBS proposed a deal with drugmaker Bristol-Myers (as it was then known) to sponsor a new TV show, Alfred Hitchcock Presents.
Jun 09, 2014
Pharmaceutical Executive
For those companies in this year's Pharm Exec Top 50, meeting the accelerating market demand for specialty products has become an acute strategic imperative.
Feb 12, 2014
By Pharmaceutical Executive Editors
In the latest issue of PEGD: Face-to-Face Meetings in the Digital Age; the US Rx Rep in the Obamacare Era; the Future of the iPad — And more
Feb 01, 2014
Pharmaceutical Executive
Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.
Jan 21, 2014
Pharmaceutical Executive
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive; muddling through is so yesterday.
Dec 01, 2013
Pharmaceutical Executive
For Patrick Lindsay, providing decision support across the full product life cycle is no stretch goal—it's today's fact of life
Mar 27, 2012
By Pharmaceutical Executive Editors
The quest for 'radical' R&D innovation is often pursued at the expense of treatments with hidden blockbuster potential, writes Bert Spilker.
Mar 07, 2012
Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
native1_300x100
lorem ipsum